NO992724L - Farmas°ytiske blandinger inneholdende N-sulfonyl-indolin-derivater - Google Patents

Farmas°ytiske blandinger inneholdende N-sulfonyl-indolin-derivater

Info

Publication number
NO992724L
NO992724L NO992724A NO992724A NO992724L NO 992724 L NO992724 L NO 992724L NO 992724 A NO992724 A NO 992724A NO 992724 A NO992724 A NO 992724A NO 992724 L NO992724 L NO 992724L
Authority
NO
Norway
Prior art keywords
amphiphilic
sulfonyl
mixtures containing
surfactant
indoline derivatives
Prior art date
Application number
NO992724A
Other languages
English (en)
Norwegian (no)
Other versions
NO992724D0 (no
Inventor
Jean-Claude Gautier
Simon John Fuller
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO992724D0 publication Critical patent/NO992724D0/no
Publication of NO992724L publication Critical patent/NO992724L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
NO992724A 1996-12-05 1999-06-04 Farmas°ytiske blandinger inneholdende N-sulfonyl-indolin-derivater NO992724L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9614957A FR2756736B1 (fr) 1996-12-05 1996-12-05 Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline
PCT/FR1997/002210 WO1998024430A1 (fr) 1996-12-05 1997-12-04 Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline

Publications (2)

Publication Number Publication Date
NO992724D0 NO992724D0 (no) 1999-06-04
NO992724L true NO992724L (no) 1999-06-04

Family

ID=9498376

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992724A NO992724L (no) 1996-12-05 1999-06-04 Farmas°ytiske blandinger inneholdende N-sulfonyl-indolin-derivater

Country Status (25)

Country Link
EP (1) EP0941090A1 (id)
JP (1) JP2000507618A (id)
KR (1) KR20000069308A (id)
CN (1) CN1239887A (id)
AR (1) AR009651A1 (id)
AU (1) AU716575B2 (id)
BR (1) BR9712406A (id)
CA (1) CA2273990A1 (id)
CO (1) CO4910129A1 (id)
DZ (1) DZ2362A1 (id)
EE (1) EE9900206A (id)
FR (1) FR2756736B1 (id)
HU (1) HUP0001386A3 (id)
ID (1) ID23373A (id)
IL (1) IL129936A0 (id)
IS (1) IS5062A (id)
MY (1) MY132819A (id)
NO (1) NO992724L (id)
NZ (1) NZ335750A (id)
RU (1) RU2174394C2 (id)
SK (1) SK75599A3 (id)
TR (1) TR199901702T2 (id)
WO (1) WO1998024430A1 (id)
YU (1) YU23099A (id)
ZA (1) ZA9710919B (id)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786486B3 (fr) * 1998-11-16 2000-12-08 Sanofi Sa Procede de preparation du (2s)-1-[(2r,3s)-5-chloro-3-(2- chlorophenyl)-1-(3,4-dimethoxy benzenesulfonyl)-3-hydroxy- 2,3-dihydro-1h-indole-2-carbonyl]pyrrolidine-2-carboxamide, de ses solvats et/ou hydrates
DE19913692A1 (de) * 1999-03-25 2000-09-28 Basf Ag Mechanisch stabile pharmazeutische Darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive Substanzen
US6437006B1 (en) 1999-09-27 2002-08-20 American Cyanamid Company Pharmaceutical carrier formulation
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
EP1175205B1 (en) 1999-11-12 2006-06-14 Abbott Laboratories Solid dispersion comprising ritonavir, fenofibrate or griseofulvin
FR2805992A1 (fr) * 2000-03-08 2001-09-14 Sanofi Synthelabo Compositions pharmaceutiques orales contenant des derives de n-sulfonylindoline
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
ITMI20011338A1 (it) 2001-06-26 2002-12-26 Farmatron Ltd Composizioni farmaceutiche orali a rilascio immediato del principio attivo
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
UA119324C2 (uk) * 2013-04-02 2019-06-10 Теміс Медікер Лімітед Композиції фармацевтично активних речовин, що містять моноетиловий ефір діетиленгліколю або інші алкільні похідні
KR102139339B1 (ko) * 2013-06-24 2020-07-29 주식회사 엘지생활건강 인돌 화합물을 포함하는 용해도가 개선된 화장료 조성물
KR102139338B1 (ko) * 2013-06-24 2020-07-29 주식회사 엘지생활건강 인돌 화합물을 포함하는 용해도가 개선된 화장료 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3237814A1 (de) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. Wasserfreie emulsionen und verwendung derselben
FR2679903B1 (fr) * 1991-08-02 1993-12-03 Elf Sanofi Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant.

Also Published As

Publication number Publication date
HUP0001386A2 (hu) 2001-04-28
SK75599A3 (en) 2000-08-14
NO992724D0 (no) 1999-06-04
CO4910129A1 (es) 2000-04-24
CA2273990A1 (fr) 1998-06-11
NZ335750A (en) 2001-06-29
EP0941090A1 (fr) 1999-09-15
DZ2362A1 (fr) 2002-12-28
IS5062A (is) 1999-06-01
FR2756736B1 (fr) 1999-03-05
AU716575B2 (en) 2000-03-02
JP2000507618A (ja) 2000-06-20
YU23099A (en) 1999-11-22
AU5326298A (en) 1998-06-29
KR20000069308A (ko) 2000-11-25
RU2174394C2 (ru) 2001-10-10
ZA9710919B (en) 1999-06-04
TR199901702T2 (en) 1999-09-21
ID23373A (id) 2000-04-20
CN1239887A (zh) 1999-12-29
IL129936A0 (en) 2000-02-29
BR9712406A (pt) 1999-08-31
FR2756736A1 (fr) 1998-06-12
EE9900206A (et) 1999-12-15
WO1998024430A1 (fr) 1998-06-11
HUP0001386A3 (en) 2002-03-28
AR009651A1 (es) 2000-04-26
MY132819A (en) 2007-10-31

Similar Documents

Publication Publication Date Title
NO992724L (no) Farmas°ytiske blandinger inneholdende N-sulfonyl-indolin-derivater
NO964813D0 (no) Fremgangsmåte for stabilisering av duocarmycinderivater
WO1997030677A3 (en) Pentafluorobenzenesulfonamides and analogs
DK0679157T3 (da) Nye 3,4-diarylthiophener og analoge deraf til anvendelse som antiinflammatoriske midler
WO2001056989A3 (en) Inhibitors of factor xa
DE69025336D1 (de) Antihypertensive Zubereitungen und deren Verwendung
AU636738B2 (en) Nematicidal compositions
NO962539D0 (no) 5-(2-imidazolinylamino)benzimidazol-derivater, deres fremstilling og deres anvendelse som -2-adreniceptor-agonister
AU698744B2 (en) Oil-in-water emulsions
DK0669935T3 (da) Forbindelser, som er anvendelige som sødemidler, og fremgangsmåde til deres fremstilling
FI961506A0 (fi) Distamysiini A -analogit antituumorisina ja antiviraalisina aineina
CA2221114A1 (en) Atherosclerosis treatment
WO2001072708A3 (en) OXINDOLE INHIBITORS OF FACTOR Xa
EA199900163A1 (ru) Акрилоил-замещенные производные дистамицина, способы их получения и их применение в качестве противоопухолевых и противовирусных средств
CA2316082A1 (en) Substituted 2-benzylamino-2-phenyl-acetamide compounds
DE3364588D1 (en) Fungicidal agent
NO951811L (no) Kinolin- og benzimidazolderivater, deres fremstilling og anvendelse
AU591932B2 (en) Nematicidal compositions
ES2077867T3 (es) 3-carbamoil-4-hidroxicumarinas antihelminticas y anticoccidiales, procedimiento de uso y composiciones.
BR9908796A (pt) Uso de compostos de macrolìdeo, método de tratamento e prevenção de ards, composição farmacêutica e composto macrolìdeo
AU1314095A (en) Oil-in-water emulsions
HUP0401194A2 (hu) Új felületaktív anyagok, ezeket tartalmazó aeroszol készítmények és alkalmazásuk
AU4435093A (en) Methods and agents for combating cockroaches
GB2276619A (en) Cyclic ketal derivatives
NO924190L (no) Fremgangsmaate for fremstilling av homogene, fine, pulverformige faststoffdispersjoner som eventuelt inneholder virksomme substanser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application